ARCHIVES

“Harm-Reduction” Products No Proven, IOM Report Says.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

USPSTF Recommends Hepatitis C Screening For Baby Boomers

June 26, 2013

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

July 9, 2010

Senate Report Calls on NCI To Expand Research in Survivorship, CAM, GYN Cancers, And Fund Five Pancreatic SPOREs

August 2, 2002

Department of Defense Offering $16 Million in Cancer Research Grants

July 22, 2011

Panel Unenthused About New Toxicity Testing Program

December 15, 1978

Fourteen Immunology RFPs Announced, NCI will Have Eight More Immunodiagnosis; $43 Million Budgeted

September 6, 1974